Add to ORKGSession: Hepatocellular Carcinoma - ClinicalConference Theme: Hepatology: The New Era Begin
Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carc...
Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have...
Keratin (KRT) 19 is a poor prognostic marker for hepatocellular carcinoma (HCC); however, regulatory...
<p>Immunohistochemical staining of CK-19 in (A) tumor tissues, (B) adjacent non-malignant tissues, a...
Background: Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical sub...
Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs) and in chol...
Abstract Objectives Cyclin-dependent kinase 19 (CDK19) is a component of the mediator coactivator co...
<p>Immunohistochemical staining of CK-19 in (A) tumor tissues, (B) adjacent non-malignant tissues, a...
This retrospective study was designed to investigate the correlation between a novel immunosubtyping...
Combinatorial analysis of H3K36me3 signature enrichment, CK19 expression and HNF1β expression in the...
Hepatocellular carcinoma (HCC) has heterogeneous molecular and pathological features and biological ...
Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical subgroups. A pr...
<div><p>This retrospective study was designed to investigate the correlation between a novel immunos...
Keratin (K)19, a biliary/hepatic progenitor cell (HPC) marker, is expressed in a subset of hepatocel...
Objective: Keratin 19 (K19) expression is a potential predictor of poor prognosis in patients with h...
Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carc...
Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have...
Keratin (KRT) 19 is a poor prognostic marker for hepatocellular carcinoma (HCC); however, regulatory...
<p>Immunohistochemical staining of CK-19 in (A) tumor tissues, (B) adjacent non-malignant tissues, a...
Background: Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical sub...
Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs) and in chol...
Abstract Objectives Cyclin-dependent kinase 19 (CDK19) is a component of the mediator coactivator co...
<p>Immunohistochemical staining of CK-19 in (A) tumor tissues, (B) adjacent non-malignant tissues, a...
This retrospective study was designed to investigate the correlation between a novel immunosubtyping...
Combinatorial analysis of H3K36me3 signature enrichment, CK19 expression and HNF1β expression in the...
Hepatocellular carcinoma (HCC) has heterogeneous molecular and pathological features and biological ...
Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical subgroups. A pr...
<div><p>This retrospective study was designed to investigate the correlation between a novel immunos...
Keratin (K)19, a biliary/hepatic progenitor cell (HPC) marker, is expressed in a subset of hepatocel...
Objective: Keratin 19 (K19) expression is a potential predictor of poor prognosis in patients with h...
Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carc...
Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have...
Keratin (KRT) 19 is a poor prognostic marker for hepatocellular carcinoma (HCC); however, regulatory...